Depression Treatment Clinic Eugene - BestMind Behavioral Health
1400 Executive Parkway, Ste 250, Eugene
4.8(166 Google reviews)
United States
7 listed treatment centers serving Eugene and the surrounding area.
1400 Executive Parkway, Ste 250, Eugene
4.8(166 Google reviews)
The cost of SPRAVATO® treatment for someone in Eugene depends on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for an estimate that includes both, rather than a medication-only quote.
Prior authorization is common. Your insurer may require documentation of earlier antidepressant trials before deciding whether to approve treatment. Ask your prescribing clinician which records are needed, including medication names, doses, treatment dates, and how you responded. Gathering available records early can help the care team submit the requested information, but it does not guarantee approval.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Oregon Medicaid coverage also depends on the plan and treatment setting. Confirm benefits directly with your insurer and ask whether the treatment center can bill your coverage; a directory listing is not confirmation of insurance participation.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Program rules apply, and assistance may not cover every part of a treatment visit. Check current eligibility and terms before budgeting around it.
Before starting Spravato, ask the center and insurer:
This directory currently has no listed SPRAVATO® treatment center in Eugene. It also has no other Oregon cities with listed centers to suggest here. That is a directory limitation, not proof that treatment is unavailable. Ask your prescribing clinician or insurer to help identify a potential location, then confirm directly that it is SPRAVATO® REMS-certified and accepting patients.
Treatment happens only in a certified healthcare setting. You self-administer the nasal spray under direct observation of a healthcare provider; it is never sent home with you. Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. Monitoring may last longer if your care team determines you are not ready to leave.
For treatment-resistant depression, the typical labeled schedule starts twice weekly for weeks 1–4, then weekly for weeks 5–8, followed by weekly or every-two-week maintenance. Your prescriber individualizes the schedule, so confirm your expected visits before arranging ongoing transportation or work leave.
You need someone else to take you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable driver and a backup plan; ask the center about its discharge requirements before relying on a hired ride.
When planning Spravato visits, allow time away from work for the appointment and transportation. If your job involves driving or machinery, discuss scheduling around the restriction. Coordinate childcare or other responsibilities in advance, and ask about appointment availability before committing to a location outside Eugene.
This directory currently has no listed SPRAVATO® treatment center in Eugene and no other listed Oregon cities to point you toward. Ask your clinician or insurer for help finding a location. Before scheduling, confirm directly that the setting is REMS-certified, offers the treatment, and is accepting new patients. Offering esketamine does not by itself confirm REMS certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are commonly required. Medicare and Oregon Medicaid may cover treatment, but neither coverage nor a center's ability to bill your plan should be assumed. Ask your insurer about both the medication and the monitoring visit, and request an estimate of your responsibility before starting.
You use the nasal spray yourself under a healthcare provider's direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and blood pressure increases. Discharge depends on your clinical status. Arrange someone else to take you home; you cannot drive until the next day after a restful sleep.
Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can mean feeling disconnected from yourself or your surroundings. Blood pressure can also increase. It is a Schedule III controlled substance. Review your health history and medications with the prescriber, and tell staff promptly about symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically warranted. Do not wait for an appointment if you need urgent help. Call or text 988 for crisis support, or call 911 in an emergency. A clinician can help assess what level of care you need.
Approved uses, nearby treatment centers, and medically sourced patient guides.